ACC 2013 schedule

Here is the page we will use to coordinate the TV events at ACC 2013. Open time slots are indicated below in red.

Filming location TBD.

---

Click on Date for Detailed Schedule

Friday March 8, 2013

Saturday March 9, 2013

Sunday March 10, 2013

---

Friday March 8, 2013

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

OPEN TIME SLOT

9:30 AM

OPEN TIME SLOT

10:00 AM

OPEN TIME SLOT

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

11:30 AM

OPEN TIME SLOT

4:30 PM

OPEN TIME SLOT

Saturday March 9, 2013

10:00 AM

10:00 AM – 10:30 AM

• Interviewee: Dr. Masahiro Natsuaki
• Topic: One-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial (NEXT)
• Embargo lift: Sunday, March 10, 2013 at 8:36 AM

10:30 AM

OPEN TIME SLOT

11:00 AM

11:00 AM – 11:30 AM

• Interviewee: Dr. Jean Claude Tardif
• Topic: Effects of the P-Selectin Antagonist Inclacumab in the Select-Acute Coronary Syndromes Trial
• Embargo lift: Sunday, March 10, 2013 at 11:21 AM

4:00 PM

4:00 PM – 4:30 PM

• Interviewee: Dr. Jane Margaret Armitage
• Topic: HPS2-THRIVE: Randomized Comparison Of Extended-Release (ER) niacin/laropiprant 2g Daily Versus Placebo in 25,673 Patients At High Risk Of Occlusive Vascular Events
• Embargo lift: Saturday, March 9, 2013 at 9:30 AM

4:30 PM

4:30 PM – 5:00 PM

• Interviewee: Dr. Anna Toso
• Topic: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome
• Embargo lift: Sunday, March 10, 2013 at 8:00 AM

Sunday March 10, 2013

10:00 AM

OPEN TIME SLOT

1:00 PM

1:00 PM – 1:30 PM

• Interviewee: Dr. Margaret Redfield
• Topic: Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX) Trial
• Embargo lift: Monday, March 11, 2013 at 11:30 AM

1:30 PM

1:30 PM – 2:00 PM

• Interviewee: Dr. Renato Lopes
• Topic: ACC Wrap-Up in Portuguese

2:00 PM

• Interviewee: Dr. Mikhail Kosiborod
• Topic: Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Randomized Clinical Trial
• Embargo lift: Sunday, March 10, 2013 at 11:57 AM

2:30 PM

• Interviewee: Dr. Freek W.A. Verheugt and Dr. J.H. Cornel
• Topic: ACC Wrap-Up from a Dutch perspective

3:00 PM

OPEN TIME SLOT

3:30 PM

OPEN TIME SLOT

4:00 PM

OPEN TIME SLOT

4:30 PM

OPEN TIME SLOT